ACNS1723, A Phase 2 Study of Dabrafenib (NSC# 763760) with Trametinib (NSC# 763093) after Local Irradiation in Newly-Diagnosed BRAFV600-Mutant High-Grade Glioma (HGG) (IND# 145355)
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
Holly Lindsay
Study ID
Protocol Number: 19-2475
More information available at ClinicalTrials.gov: NCT03919071
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers